Allgens Ebit vs Selling And Marketing Expenses Analysis

688613 Stock

17.12 0.36 2.06%

Allgens Medical financial indicator trend analysis is way more than just evaluating Allgens Medical Tech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Allgens Medical Tech is a good investment. Please check the relationship between Allgens Medical Ebit and its Selling And Marketing Expenses accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allgens Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Ebit vs Selling And Marketing Expenses

Ebit vs Selling And Marketing Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Allgens Medical Tech Ebit account and Selling And Marketing Expenses. At this time, the significance of the direction appears to have strong relationship.

The correlation between Allgens Medical's Ebit and Selling And Marketing Expenses is 0.79. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Selling And Marketing Expenses in the same time period over historical financial statements of Allgens Medical Technology, assuming nothing else is changed. The correlation between historical values of Allgens Medical's Ebit and Selling And Marketing Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of Allgens Medical Technology are associated (or correlated) with its Selling And Marketing Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling And Marketing Expenses has no effect on the direction of Ebit i.e., Allgens Medical's Ebit and Selling And Marketing Expenses go up and down completely randomly.

Correlation Coefficient

0.79

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Ebit

Selling And Marketing Expenses

Most indicators from Allgens Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Allgens Medical Tech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allgens Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

The current year's Selling General Administrative is expected to grow to about 92.6 M, whereas Tax Provision is projected to grow to (3.7 M).

	2021	2022	2023	2024 (projected)
Gross Profit	201.5M	204.5M	187.2M	167.0M
Total Revenue	236.1M	245.3M	226.5M	200.4M

Gross Profit Total Revenue

Allgens Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Non Current Liabilities Total	Short Long Term Debt Total	Long Term Debt	Net Receivables	Short Term Investments	Net Invested Capital
Total Assets		0.17	0.67	0.99	0.87	-0.86	0.93	0.82	0.87	0.96	0.57	0.96	0.98	0.62	-0.87	0.98	0.85	1.0	0.74	0.97	0.91	0.91	0.44	0.88	0.94	0.96
Other Current Liab	0.17		0.76	0.08	0.58	0.03	-0.06	0.22	0.14	0.39	0.02	0.08	0.16	-0.34	-0.42	0.04	0.62	0.1	0.68	0.31	0.41	-0.05	0.36	-0.19	-0.13	-0.12
Total Current Liabilities	0.67	0.76		0.59	0.93	-0.44	0.56	0.7	0.52	0.83	0.1	0.66	0.7	0.12	-0.79	0.54	0.94	0.61	0.97	0.74	0.79	0.47	0.26	0.41	0.46	0.45
Total Stockholder Equity	0.99	0.08	0.59		0.81	-0.87	0.94	0.81	0.87	0.93	0.59	0.95	0.98	0.66	-0.83	0.99	0.79	1.0	0.68	0.94	0.87	0.92	0.42	0.91	0.96	0.98
Property Plant And Equipment Net	0.87	0.58	0.93	0.81		-0.62	0.77	0.75	0.7	0.97	0.33	0.85	0.87	0.38	-0.93	0.77	1.0	0.83	0.94	0.92	0.95	0.7	0.4	0.64	0.7	0.71
Net Debt	-0.86	0.03	-0.44	-0.87	-0.62		-0.81	-0.66	-0.97	-0.75	-0.67	-0.82	-0.82	-0.41	0.61	-0.87	-0.62	-0.87	-0.56	-0.73	-0.71	-0.93	-0.48	-0.7	-0.79	-0.89
Retained Earnings	0.93	-0.06	0.56	0.94	0.77	-0.81		0.77	0.76	0.88	0.43	0.98	0.95	0.7	-0.79	0.91	0.73	0.93	0.65	0.86	0.83	0.89	0.18	0.91	0.97	0.96
Accounts Payable	0.82	0.22	0.7	0.81	0.75	-0.66	0.77		0.6	0.83	0.22	0.78	0.89	0.47	-0.62	0.82	0.71	0.81	0.77	0.77	0.63	0.61	0.04	0.82	0.8	0.75
Cash	0.87	0.14	0.52	0.87	0.7	-0.97	0.76	0.6		0.79	0.76	0.81	0.82	0.33	-0.69	0.86	0.7	0.88	0.62	0.78	0.79	0.91	0.6	0.62	0.74	0.86
Non Current Assets Total	0.96	0.39	0.83	0.93	0.97	-0.75	0.88	0.83	0.79		0.45	0.93	0.96	0.52	-0.93	0.9	0.95	0.94	0.87	0.97	0.95	0.82	0.41	0.79	0.85	0.86
Non Currrent Assets Other	0.57	0.02	0.1	0.59	0.33	-0.67	0.43	0.22	0.76	0.45		0.44	0.51	0.1	-0.42	0.58	0.35	0.59	0.21	0.47	0.5	0.55	0.6	0.31	0.49	0.6
Cash And Short Term Investments	0.96	0.08	0.66	0.95	0.85	-0.82	0.98	0.78	0.81	0.93	0.44		0.96	0.61	-0.88	0.92	0.83	0.95	0.72	0.93	0.9	0.9	0.25	0.88	0.94	0.94
Common Stock Shares Outstanding	0.98	0.16	0.7	0.98	0.87	-0.82	0.95	0.89	0.82	0.96	0.51	0.96		0.59	-0.84	0.96	0.84	0.98	0.78	0.94	0.87	0.85	0.29	0.89	0.95	0.94
Inventory	0.62	-0.34	0.12	0.66	0.38	-0.41	0.7	0.47	0.33	0.52	0.1	0.61	0.59		-0.42	0.68	0.32	0.64	0.2	0.58	0.45	0.65	0.21	0.83	0.76	0.69
Other Current Assets	-0.87	-0.42	-0.79	-0.83	-0.93	0.61	-0.79	-0.62	-0.69	-0.93	-0.42	-0.88	-0.84	-0.42		-0.78	-0.93	-0.84	-0.76	-0.95	-0.98	-0.74	-0.4	-0.67	-0.74	-0.75
Other Stockholder Equity	0.98	0.04	0.54	0.99	0.77	-0.87	0.91	0.82	0.86	0.9	0.58	0.92	0.96	0.68	-0.78		0.74	0.99	0.64	0.92	0.82	0.91	0.43	0.92	0.95	0.97
Total Liab	0.85	0.62	0.94	0.79	1.0	-0.62	0.73	0.71	0.7	0.95	0.35	0.83	0.84	0.32	-0.93	0.74		0.8	0.93	0.91	0.95	0.69	0.43	0.58	0.66	0.68
Total Current Assets	1.0	0.1	0.61	1.0	0.83	-0.87	0.93	0.81	0.88	0.94	0.59	0.95	0.98	0.64	-0.84	0.99	0.8		0.69	0.95	0.88	0.92	0.44	0.89	0.95	0.97
Intangible Assets	0.74	0.68	0.97	0.68	0.94	-0.56	0.65	0.77	0.62	0.87	0.21	0.72	0.78	0.2	-0.76	0.64	0.93	0.69		0.76	0.8	0.56	0.3	0.49	0.55	0.56
Common Stock	0.97	0.31	0.74	0.94	0.92	-0.73	0.86	0.77	0.78	0.97	0.47	0.93	0.94	0.58	-0.95	0.92	0.91	0.95	0.76		0.95	0.84	0.45	0.82	0.87	0.87
Non Current Liabilities Total	0.91	0.41	0.79	0.87	0.95	-0.71	0.83	0.63	0.79	0.95	0.5	0.9	0.87	0.45	-0.98	0.82	0.95	0.88	0.8	0.95		0.82	0.5	0.67	0.77	0.8
Short Long Term Debt Total	0.91	-0.05	0.47	0.92	0.7	-0.93	0.89	0.61	0.91	0.82	0.55	0.9	0.85	0.65	-0.74	0.91	0.69	0.92	0.56	0.84	0.82		0.53	0.8	0.86	0.93
Long Term Debt	0.44	0.36	0.26	0.42	0.4	-0.48	0.18	0.04	0.6	0.41	0.6	0.25	0.29	0.21	-0.4	0.43	0.43	0.44	0.3	0.45	0.5	0.53		0.13	0.21	0.34
Net Receivables	0.88	-0.19	0.41	0.91	0.64	-0.7	0.91	0.82	0.62	0.79	0.31	0.88	0.89	0.83	-0.67	0.92	0.58	0.89	0.49	0.82	0.67	0.8	0.13		0.97	0.92
Short Term Investments	0.94	-0.13	0.46	0.96	0.7	-0.79	0.97	0.8	0.74	0.85	0.49	0.94	0.95	0.76	-0.74	0.95	0.66	0.95	0.55	0.87	0.77	0.86	0.21	0.97		0.98
Net Invested Capital	0.96	-0.12	0.45	0.98	0.71	-0.89	0.96	0.75	0.86	0.86	0.6	0.94	0.94	0.69	-0.75	0.97	0.68	0.97	0.56	0.87	0.8	0.93	0.34	0.92	0.98

Click cells to compare fundamentals

Allgens Medical Account Relationship Matchups

Allgens Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	716.1M	804.9M	1.4B	1.5B	1.5B	1.1B
Other Current Liab	78.6M	67.7M	32.8M	25.4M	307.0K	291.6K
Total Current Liabilities	86.0M	71.4M	55.2M	48.5M	50.8M	60.0M
Total Stockholder Equity	532.9M	622.7M	1.2B	1.3B	1.4B	917.0M
Property Plant And Equipment Net	192.7M	205.6M	195.5M	188.8M	186.6M	177.8M
Net Debt	(28.9M)	31.0M	(330.7M)	(198.3M)	(178.5M)	(169.5M)
Retained Earnings	4.6M	83.1M	190.8M	239.2M	276.0M	289.8M
Accounts Payable	4.8M	1.1M	3.3M	7.4M	10.4M	5.2M
Cash	75.4M	21.1M	411.3M	259.9M	161.3M	161.6M
Non Current Assets Total	226.6M	250.5M	305.2M	316.9M	325.5M	257.9M
Non Currrent Assets Other	1.2M	8.6M	70.9M	86.1M	4.9M	4.6M
Cash And Short Term Investments	454.7M	491.8M	1.1B	1.1B	1.2B	1.3B
Common Stock Shares Outstanding	99.7M	99.9M	119.6M	134.1M	133.3M	120.2M
Liabilities And Stockholders Equity	716.1M	804.9M	1.4B	1.5B	1.7B	960.4M
Inventory	7.5M	21.9M	19.0M	18.3M	32.7M	20.0M
Other Current Assets	10.8M	17.2M	4.1M	3.9M	31.3M	29.7M
Other Stockholder Equity	428.3M	439.6M	920.1M	930.3M	1.1B	625.8M
Total Liab	152.3M	153.2M	155.5M	133.5M	122.6M	125.5M
Total Current Assets	489.4M	554.5M	1.1B	1.1B	1.2B	807.2M
Intangible Assets	27.0M	25.8M	24.6M	23.4M	22.1M	24.9M
Non Current Liabilities Total	66.3M	81.9M	100.3M	85.0M	71.8M	76.5M

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

Other Information on Investing in Allgens Stock

Balance Sheet is a snapshot of the financial position of Allgens Medical Tech at a specified time, usually calculated after every quarter, six months, or one year. Allgens Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Allgens Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Allgens currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Allgens Ebit vs Selling And Marketing Expenses Analysis

Ebit vs Selling And Marketing Expenses

Ebit vs Selling And Marketing Expenses Correlation Analysis

Correlation Coefficient

Ebit

Selling And Marketing Expenses

Allgens Medical fundamental ratios Correlations

Allgens Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Allgens Medical fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Allgens Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Stockholder Equity
Total Liab	+ 1.0	Property Plant And Equipment Net
Total Stockholder Equity	+ 0.99	Total Assets
Other Stockholder Equity	+ 0.99	Total Stockholder Equity
Total Current Assets	+ 0.99	Other Stockholder Equity

Non Current Liabilities Total	- 0.98	Other Current Assets
Cash	- 0.97	Net Debt
Common Stock	- 0.95	Other Current Assets
Total Liab	- 0.93	Other Current Assets
Other Current Assets	- 0.93	Non Current Assets Total
Short Long Term Debt Total	- 0.93	Net Debt